These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2452 related articles for article (PubMed ID: 7745975)

  • 1. Combined local hyperthermia and immunotherapy treatment of an experimental subcutaneous murine melanoma.
    Geehan DM; Fabian DF; Lefor AT
    J Surg Oncol; 1995 May; 59(1):35-9. PubMed ID: 7745975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and whole-body hyperthermia as combined modality treatment of a subcutaneous murine sarcoma.
    Geehan DM; Fabian DF; Lefor AT
    J Surg Oncol; 1993 Jul; 53(3):180-3. PubMed ID: 8331940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local hyperthermia abrogates the anti-immunotherapeutic effect of interleukin-8.
    Geehan DM; Fabian DF; Lefor AT
    J Surg Oncol; 1994 Jun; 56(2):102-6. PubMed ID: 8007673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
    Ito A; Tanaka K; Kondo K; Shinkai M; Honda H; Matsumoto K; Saida T; Kobayashi T
    Cancer Sci; 2003 Mar; 94(3):308-13. PubMed ID: 12824927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapy.
    Green DM; Samulski TV; Vervaert C; Halperin EC; Oleson JR; Seigler H
    J Surg Oncol; 1990 Aug; 44(4):256-9. PubMed ID: 2385103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
    Winkelhake JL; Stampfl S; Zimmerman RJ
    Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gamma.
    Silagi S; Dutkowski R; Schaefer A
    Int J Cancer; 1988 Feb; 41(2):315-22. PubMed ID: 3123404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of electrotherapy alone or in combination with interleukin-2 in mice with sarcoma and melanoma tumors.
    Sersa G; Miklavcic D; Batista U; Novaković S; Bobanović F; Vodovnik L
    Anticancer Drugs; 1992 Jun; 3(3):253-60. PubMed ID: 1525406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
    Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
    Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma.
    Palomares T; Bilbao P; Alonso-Varona A; Barberá-Guillem E
    Cancer Immunol Immunother; 1995 May; 40(5):292-8. PubMed ID: 7600560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental approaches for the treatment of murine B16 melanomas of various sizes. I: Local injection of ethanol with a combination of interleukin-2 or microwaval hyperthermia for B16 melanomas with a size of less than 7 mm in diameter.
    Nakayama J; Kokuba H; Kobayashi J; Yoshida Y; Hori Y
    J Dermatol Sci; 1997 Aug; 15(2):75-81. PubMed ID: 9279687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful immunotherapy of mouse melanoma and sarcoma with recombinant interleukin-2 and cyclophosphamide.
    Silagi S; Schaefer AE
    J Biol Response Mod; 1986 Oct; 5(5):411-22. PubMed ID: 3490544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.
    Werthmöller N; Frey B; Rückert M; Lotter M; Fietkau R; Gaipl US
    Int J Hyperthermia; 2016; 32(1):23-30. PubMed ID: 26754406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha mediates the antitumor effect of combined interleukin-2 and whole body hyperthermia.
    Fritz KL; Koziol S; Fabian DF; Lefor AT
    J Surg Res; 1996 Jan; 60(1):55-60. PubMed ID: 8592432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
    Lu L; Xiao M; Wu B; Wang WX; Yan WR; Broxmeyer HE; Shen RN
    Int J Hematol; 1993 Oct; 58(3):139-52. PubMed ID: 8148492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL-2 and surgical resection increased survival and tumor control in metastatic melanoma model.
    Shrayer D; Koness J; Kouttab N; Bogaars H; Hearing VJ; Gersten DM; Maizel A; Wanebo H
    J Surg Oncol; 1993 Mar; 52(3):142-9. PubMed ID: 8441268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental approaches for the treatment of murine B16 melanomas of various sizes. II: Injection of ethanol with combinations of beta-interferon and microwaval hyperthermia for B16 melanomas with a size of greater than 10 mm in diameter.
    Nakayama J; Kokuba H; Kobayashi J; Yoshida Y; Hori Y
    J Dermatol Sci; 1997 Aug; 15(2):82-8. PubMed ID: 9279688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of lymph node and pulmonary metastases after local irradiation and hyperthermia of footpad melanomas.
    Nathanson SD; Nelson L; Anaya P; Havstad S; Hetzel FW
    Clin Exp Metastasis; 1991; 9(4):377-92. PubMed ID: 1868628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma.
    Safwat A; Aggerholm N; Roitt I; Overgaard J; Hokland M
    J Exp Ther Oncol; 2003; 3(4):161-8. PubMed ID: 14567287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 123.